Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Revitol Cellulite Cream

Surgical Mask And Respirator Use Should Be Encouraged During Swine Flu Outbreak
A new article in the journal Risk Analysis assessed various ways in which aerosol transmission of the flu, a central mode of diffusion which involves breathing droplets in the air, can be reduced. Results show that face protection is a key infection control measure for influenza and can thus affect how people should try to protect themselves from the swine flu. Don't forget to buy zoloft online no prescription.

Drug That Targets Vasculature Growth Attacks Aggressive Thyroid Cancer
A medication that helps stop the growth of new blood vessels has produced dramatic benefits for some patients with aggressive thyroid cancer, research from Mayo Clinic indicates.

generic viagra online


News of the day
Injectable Drugs Benefiting From Advances In Evolving Device Designs
As life expectancy increases in developed economies, the healthcare industry is preparing for a number of new challenges as well as opportunities. A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.
Oncology

Drug Benefit Case Studies Needed

A well-crafted case study is a powerful educational and marketing tool. The Pharmacy Benefit Management Institute"s (PBMI) 15th Anniversary Drug Benefit Conference offers industry experts an opportunity to present case studies that showcase solutions to critical drug benefit challenges. Speaker proposals will be accepted until August 14, 2009 for the conference to be held February 17-19, 2010 in Phoenix. "PBMI has a long-standing reputation for educating the industry on the best approaches for managing the drug benefit," says Dana H. Felthouse, MBA, president of PBMI. "We want conference proposals that educate employers, health plans, union groups, and third-party administrators. These stakeholders say they benefit most from case studies that show how other purchasers are overcoming challenges similar to their own." Proposals for presentations that provide insight on drug benefit trends also are welcome. Speakers are needed for general sessions and breakout sessions in three tracks: HR Perspectives, Managed Care Pharmacy Perspectives, and Industry Trends. Conference attendees typically include human re generalists as well as benefits specialists and managed care pharmacy professionals. Some attendees want to know more about the fundamentals of pharmacy benefit management while others want more technical information. PBMI will offer sessions that meet both needs. The conference will offer 12 continuing pharmacy education (CPE) credits as well as continuing education credit for human re professionals. Prospective speakers should submit proposals at http://pbmi.com/SpeakerPresentation.asp. All speakers will receive free registration to the 2-day conference. The Pharmacy Benefit Management Institute provides research, continuing education and Web res that help health care benefit executives work effectively with pharmacy benefit managers to improve the design and management of drug benefit programs. Learn more at http://www.pbmi.com. To view this press release and other PBMI news, please visit http://www.pbmi.com/news-releases.asp. Pharmacy Benefit Management Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009